Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 206

Rallybio tallies up $145m for series B

The rare disease drug developer pulled in $145m through a round led by Pivotal BioVenture Partners and backed by Mitsui and Fidelity.

May 20, 2020

SQZ sequences $65m series D

GV and Illumina Ventures returned to reinvest in cellular therapy developer SQZ Biotechnologies, which has now raised at least $166m to date.

May 20, 2020

Gatt gets series B funding

Johnson & Johnson Innovation – JJDC was among the investors in an $11.7m round for blood sealant technology developer Gatt Technologies.

May 19, 2020

Holmusk holds down series A funding

Holmusk, developer of a behavioural healthcare evidence platform, has completed a $21.5m round co-led by corporate venturing unit Optum Ventures.

May 19, 2020

ADC accelerates to $233m IPO

The AstraZeneca cancer drug spinoff floated above its range in an upsized initial public offering and now has a market cap topping $2bn.

May 18, 2020

Corporate venturing deal net: 11-15 May 2020

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

May 15, 2020

Legend Biotech embarks on IPO quest

Genscript Biotech’s subsidiary Legend Biotech, which agreed to an investment worth nearly $151m from Eli Lilly and Johnson & Johnson last month, has filed to go public.

May 15, 2020

Clear Labs experiments with $18m round

GV and Tyson Ventures invested in an $18m funding round for Clear Labs that has now raised $62m altogether from backers also including Dentsu and Tencent.

May 15, 2020

GreenLight clears $17m

Continental Grain-backed RNA material producer GreenLight Biosciences is hoping to supply ingredients for RNA-based coronavirus vaccines after securing $17m in funding.

May 15, 2020

Intel strikes a dozen deals

Intel Capital has invested at least $132m in 12 companies so far this year and is on its way to putting between $300m and $500m into startups by the end of 2020.

May 14, 2020

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here